Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/1273
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMolassiotis, Alexanderen_UK
dc.contributor.authorMargulies, Anitaen_UK
dc.contributor.authorFernandez-Ortega, Pazen_UK
dc.contributor.authorPud, Doriten_UK
dc.contributor.authorPanteli, Vassilikien_UK
dc.contributor.authorBruyns, Ingriden_UK
dc.contributor.authorScott, Juliaen_UK
dc.contributor.authorGudmundsdottir, Gudbjorgen_UK
dc.contributor.authorBrowall, Mariaen_UK
dc.contributor.authorMadsen, Elinen_UK
dc.contributor.authorOzden, Gultenen_UK
dc.contributor.authorMagri, Miriamen_UK
dc.contributor.authorSelvekerova, Sarkaen_UK
dc.contributor.authorPlatin, Nurgunen_UK
dc.contributor.authorKearney, Noraen_UK
dc.contributor.authorPatiraki, Elisabethen_UK
dc.date.accessioned2017-09-22T23:55:16Z-
dc.date.available2017-09-22T23:55:16Zen_UK
dc.date.issued2005-05en_UK
dc.identifier.urihttp://hdl.handle.net/1893/1273-
dc.description.abstractSummary This study reports upon a descriptive cross-sectional survey assessing the use of complementary and alternative medicine (CAM) in patients with haematological cancers. Twelve European countries contributed data from patients with haematological cancers, as part of a larger study. Sixty-eight patients with haematological cancer participated. Among the participants, 26.5% used some form of CAM after the cancer diagnosis. The most common therapies used were homeopathy (38.9%), herbal medicine (22.2%) various psychic therapies, such as use of mediums, healers, rebirthing or past life regression therapy (22.2%). A particular profile of a CAM user was not evident in the sample. Moderate levels of satisfaction with CAM were reported. Patients commonly used CAM to increase the ability of their body to fight cancer and to improve physical and emotional wellbeing. Information about CAM was received mainly from friends or family. As CAM use in patients with haematological malignancies is common, clinicians should assist patients who want to use CAM to make an appropriate decision, and improve communication with them about CAM use in an open and non-judgemental dialogue.en_UK
dc.language.isoenen_UK
dc.publisherElsevieren_UK
dc.relationMolassiotis A, Margulies A, Fernandez-Ortega P, Pud D, Panteli V, Bruyns I, Scott J, Gudmundsdottir G, Browall M, Madsen E, Ozden G, Magri M, Selvekerova S, Platin N, Kearney N & Patiraki E (2005) Complementary and alternative medicine use in patients with haematological malignancies in Europe. Complementary Therapies in Clinical Practice, 11 (2), pp. 105-110. https://doi.org/10.1016/j.ctcp.2004.12.005en_UK
dc.rightsThe publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author; you can only request a copy if you wish to use this work for your own research or private study.en_UK
dc.rights.urihttp://www.rioxx.net/licenses/under-embargo-all-rights-reserveden_UK
dc.subjectHaematologic cancersen_UK
dc.subjectmyelomaen_UK
dc.subjectlymphomaen_UK
dc.subjectCancer Alternative treatmenten_UK
dc.subjectAlternative Medicine methodsen_UK
dc.subjectBlood cells Examinationen_UK
dc.subjectOncologyen_UK
dc.titleComplementary and alternative medicine use in patients with haematological malignancies in Europeen_UK
dc.typeJournal Articleen_UK
dc.rights.embargodate3000-01-01en_UK
dc.rights.embargoreason[Molassiotis - Complementary and alternative medicine use in patients with haematological malignancies in Europe.pdf] We would like to delay access to this to article and request that the 'Request from author' option be added to this paper. The publisher does not allow this work to be made publicly available in this Repository therefore there is an embargo on the full text of the work.en_UK
dc.identifier.doi10.1016/j.ctcp.2004.12.005en_UK
dc.identifier.pmid15955292en_UK
dc.citation.jtitleComplementary Therapies in Clinical Practiceen_UK
dc.citation.issn1744-3881en_UK
dc.citation.volume11en_UK
dc.citation.issue2en_UK
dc.citation.spage105en_UK
dc.citation.epage110en_UK
dc.citation.publicationstatusPublisheden_UK
dc.citation.peerreviewedRefereeden_UK
dc.type.statusVoR - Version of Recorden_UK
dc.author.emailnora.kearney@stir.ac.uken_UK
dc.contributor.affiliationUniversity of Manchesteren_UK
dc.contributor.affiliationUniversity Hospital Zurichen_UK
dc.contributor.affiliationInstitut CatalĂ  Oncologia ICOen_UK
dc.contributor.affiliationUniversity of Haifaen_UK
dc.contributor.affiliationGreek Oncology Nursing Societyen_UK
dc.contributor.affiliationBelgian Society of Oncology Nursingen_UK
dc.contributor.affiliationHS UG Regulated - Stirling - LEGACYen_UK
dc.contributor.affiliationDepartment of Oncology, Landspitalien_UK
dc.contributor.affiliationSahlgrenska University Hospital, Swedenen_UK
dc.contributor.affiliationAarhus University Hospitalen_UK
dc.contributor.affiliationGazi University Hospitalen_UK
dc.contributor.affiliationUniversity of Milanen_UK
dc.contributor.affiliationMasaryk Memorial Cancer Instituteen_UK
dc.contributor.affiliationKoc Universityen_UK
dc.contributor.affiliationCancer Care Research Centre - LEGACYen_UK
dc.contributor.affiliationGreek Oncology Nursing Societyen_UK
dc.identifier.scopusid2-s2.0-18244368462en_UK
dc.identifier.wtid814508en_UK
dcterms.dateAccepted2005-05-31en_UK
dc.date.filedepositdate2009-06-02en_UK
rioxxterms.typeJournal Article/Reviewen_UK
rioxxterms.versionVoRen_UK
local.rioxx.authorMolassiotis, Alexander|en_UK
local.rioxx.authorMargulies, Anita|en_UK
local.rioxx.authorFernandez-Ortega, Paz|en_UK
local.rioxx.authorPud, Dorit|en_UK
local.rioxx.authorPanteli, Vassiliki|en_UK
local.rioxx.authorBruyns, Ingrid|en_UK
local.rioxx.authorScott, Julia|en_UK
local.rioxx.authorGudmundsdottir, Gudbjorg|en_UK
local.rioxx.authorBrowall, Maria|en_UK
local.rioxx.authorMadsen, Elin|en_UK
local.rioxx.authorOzden, Gulten|en_UK
local.rioxx.authorMagri, Miriam|en_UK
local.rioxx.authorSelvekerova, Sarka|en_UK
local.rioxx.authorPlatin, Nurgun|en_UK
local.rioxx.authorKearney, Nora|en_UK
local.rioxx.authorPatiraki, Elisabeth|en_UK
local.rioxx.projectInternal Project|University of Stirling|https://isni.org/isni/0000000122484331en_UK
local.rioxx.freetoreaddate3000-01-01en_UK
local.rioxx.licencehttp://www.rioxx.net/licenses/under-embargo-all-rights-reserved||en_UK
local.rioxx.filenameMolassiotis - Complementary and alternative medicine use in patients with haematological malignancies in Europe.pdfen_UK
local.rioxx.filecount1en_UK
local.rioxx.source1744-3881en_UK
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles

Files in This Item:
File Description SizeFormat 
Molassiotis - Complementary and alternative medicine use in patients with haematological malignancies in Europe.pdfFulltext - Published Version178.88 kBAdobe PDFUnder Embargo until 3000-01-01    Request a copy


This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.